|Articles|June 1, 2020 (Updated: November 15, 2020)
- Pharmaceutical Executive-06-01-2020
- Volume 40
- Issue 6
Pharmaceutical Executive, June 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Pharm Exec's Top 50 Companies 2020over 5 years ago
Better ESG Communication with Investorsover 5 years ago
Will the Biopharma Leaders Please Take the Stage!over 5 years ago
Delivering Hope in a Pandemicover 5 years ago
The Specter of Compulsory Licensing Haunts Vaccine Debateover 5 years ago
Pivotal Moments: How Leaders Can Prepare for the Unexpectedover 5 years ago
How to Thank a Physician Post-COVID-19over 5 years ago
Spotlight on Science Gives Public New Perspectiveover 5 years ago
Rare Insights: Arndt Rolfs, CENTOGENEover 5 years ago
FDA’s Emergency Use Process Under ScrutinyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5
